Beate Katz

Title: Beate Katz: Innovator in Pharmaceutical Compositions

Introduction

Beate Katz is a prominent inventor based in Steinbrunn, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions related to tolperisone. With a total of 2 patents, her work focuses on improving therapeutic methods and formulations.

Latest Patents

Katz's latest patents include innovative approaches to tolperisone. The first patent discusses compositions of tolperisone, which relate to a pharmaceutically acceptable salt or hydrate with limited exposure to 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO). This patent outlines methods of producing tolperisone while ensuring that the levels of 4-MMPPO remain tolerable for subjects. The second patent focuses on methods of administering tolperisone to individuals in need, emphasizing the importance of limiting exposure to 4-MMPPO during treatment.

Career Highlights

Beate Katz has established herself as a key figure in the pharmaceutical industry. Her work at Sanochemia Pharmazeutika AG has allowed her to explore and develop innovative solutions that enhance patient care. Her dedication to research and development has led to advancements in the therapeutic applications of tolperisone.

Collaborations

Katz collaborates with notable colleagues, including Federico Gaeta and Klaus Gerdes. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Beate Katz's contributions to the field of pharmaceuticals, particularly through her patents on tolperisone, highlight her role as an influential inventor. Her work continues to impact the industry positively, paving the way for improved therapeutic methods.